切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (03) : 221 -225. doi: 10.3877/cma.j.issn.2095-3232.2018.03.013

所属专题: 文献

临床研究

超声造影在肝硬化结节恶变筛查中的价值
陈佳鑫1, 吴莉莉1, 郑荣琴1,()   
  1. 1. 510630 广州,中山大学附属第三医院超声科
  • 收稿日期:2018-01-29 出版日期:2018-06-10
  • 通信作者: 郑荣琴
  • 基金资助:
    广东省自然科学基金(2016A030313205); 广东省科技计划项目(2015A020214009)

Value of contrast-enhanced ultrasonography in screening of malignancy of liver cirrhotic nodules

Jiaxin Chen1, Lili Wu1, Rongqin Zheng1,()   

  1. 1. Department of Ultrasound, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2018-01-29 Published:2018-06-10
  • Corresponding author: Rongqin Zheng
  • About author:
    Corresponding author: Zheng Rongqin, Email:
引用本文:

陈佳鑫, 吴莉莉, 郑荣琴. 超声造影在肝硬化结节恶变筛查中的价值[J/OL]. 中华肝脏外科手术学电子杂志, 2018, 07(03): 221-225.

Jiaxin Chen, Lili Wu, Rongqin Zheng. Value of contrast-enhanced ultrasonography in screening of malignancy of liver cirrhotic nodules[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(03): 221-225.

目的

探讨超声造影(CEUS)在肝硬化结节恶变筛查中的价值。

方法

回顾性分析2012年1月至2016年12月中山大学附属第三医院行超声检查随访的25例患者临床资料。患者均签署知情同意书,符合医学伦理学规定。患者均为男性;年龄33~82岁,中位年龄55岁;共29个肝硬化结节。所有患者均接受规律的超声检查随访,均接受常规超声和CEUS检查,记录结节的直径、内部血流信号、超声造影增强模式等。结节直径比较采用t检验,超声造影模式比较采用Fisher确切概率法,诊断试验采用受试者工作特征(ROC)曲线。

结果

随访过程中,14个肝硬化结节恶变为肝细胞癌(肝癌)。发生恶变的结节直径(19±8)mm较恶变前(16±7) mm明显增大(t=2.682,P<0.05)。随着结节恶变,结节CEUS动脉期逐渐由等增强(12/14)转变为高增强(13/14),门静脉期/延迟期由等增强(13/14)转变为低增强(13/14),差异有统计学意义(P<0.05)。AFP、常规超声、CEUS诊断肝硬化结节恶变的曲线下面积分别为0.607、0.679、1,差异有统计学意义(Z=4.837,6.904;P<0.05)。

结论

在肝硬化结节的连续随访过程中,CEUS能早期发现恶变结节内部血流动力学变化,较常规超声具有更好的诊断价值。

Objective

To explore the value of contrast-enhanced ultrasonography (CEUS) in the screening of malignant transformation from cirrhotic nodules.

Methods

Clinical data of 25 patients who were followed up by ultrasonography in the Third Affiliated Hospital of Sun Yat-sen University from January 2012 to December 2016 were analyzed retrospectively. The informed consents of all patients were obtained and the local ethical committee approval was received. All patients were males, aged 33-82 years old, with the median age of 55 years old, and with a total of 29 cirrhotic nodules. All patients were followed up regularly by ultrasonography which included conventional ultrasound and CEUS. The diameter, internal blood flow signal and CEUS features of the nodules were recorded. The diameter was compared by t test, and the CEUS features by Fisher's exact probability test. ROC curve was used for diagnostic test.

Results

During the follow-up, 14 cirrhotic nodules turned into hepatocellular carcinoma (HCC). The diameter of malignant nodule (19±8) mm was significantly higher than (16±7) mm before malignant change (t=2.682, P<0.05). As the nodules transformed to malignancy, in the arterial phase of CEUS, signals changed gradually from equal enhancement (12/14) to hyper enhancement (13/14), and in the portal venous phase or delayed phase, it changed from equal enhancement (13/14) to low enhancement (13/14), where significant difference was observed (P<0.05). The area under the curve of AFP, conventional ultrasound and CEUS in diagnosing malignancy of cirrhotic nodules was 0.607, 0.679 and 1, respectively, where significant differences were observed (Z=4.837, 6.904, P<0.05).

Conclusion

In the continuous follow-up of cirrhotic nodules, CEUS can detect the hemodynamic changes in malignant nodules early, which has better diagnostic value than conventional ultrasound.

表1 恶变组和非恶变组肝硬化结节常规超声检查征象动态演变
表2 恶变组和非恶变组肝硬化结节超声造影检查征象动态演变
图1 肝硬化结节常规超声及超声造影图
图2 AFP、CUS、CEUS诊断肝硬化结节恶变的ROC曲线
[1]
McGuire S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015[J]. Adv Nutr, 2016, 7(2):418-419.
[2]
Liu P, Hsu CY, Hsia CY, et al. Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma ≤2 cm in a propensity score model[J]. Ann Surg, 2016, 263(3):538-545.
[3]
Sato T, Tateishi R, Yoshida H, et al. Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C[J]. Hepatol Int, 2009, 3(4):544-550.
[4]
Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2004, 130(7):417-422.
[5]
Del Poggio P, Olmi S, Ciccarese F, et al. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2014, 12(11):1927-1933.
[6]
Van Beers BE, Daire JL, Garteiser P. New imaging techniques for liver diseases [J]. J Hepatol, 2015, 62(3):690-700.
[7]
Kobayashi M, Ikeda K, Hosaka T, et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis[J]. Cancer, 2006, 106(3):636-647.
[8]
Sato T, Kondo F, Ebara M, et al. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study[J]. Hepatol Int, 2015, 9(2):330-336.
[9]
Wu S, Tu R, Liu G, et al. Dynamic changes in ultrasound characteristics of nodules in cirrhotic liver and their implications in surveillance for malignancy[J]. J Med Ultrason, 2014, 41(2):165-171.
[10]
Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2011, 53(3):1020-1022.
[11]
European Association For the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol, 2012, 56(4):908-943.
[12]
An C, Rakhmonova G, Choi JY, et al. Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm[J]. Clin Mol Hepatol, 2016, 22(2):296-307.
[13]
Fraum TJ, Tsai R, Rohe E, et al. Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014[J]. Radiology, 2018, 286(1):158-172.
[14]
International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia[J]. Hepatology, 2009, 49(2):658-664.
[15]
Ojima H, Masugi Y, Tsujikawa H, et al. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions[J]. Cancer Sci, 2016, 107(4):543-550.
[16]
Boas FE, Do B, Louie JD, et al. Optimal imaging surveillance schedules after liver-directed therapy for hepatocellular carcinoma[J]. J Vasc Interv Radiol, 2015, 26(1):69-73.
[17]
Lin XJ, Chong Y, Guo ZW, et al. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study[J]. Lancet Oncol, 2015, 16(7):804-815.
[18]
Shin SK, Kim YS, Choi SJ, et al. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis[J]. Dig Liver Dis, 2015, 47(9):775-782.
[19]
Terzi E, Iavarone M, Pompili M, et al. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules[J]. J Hepatol, 2018, 68(3):485-492.
[20]
Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS[J]. Ultrasound Med Biol, 2013, 39(2):187-210.
[21]
Wang YC, Chou CT, Lin CP, et al. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images[J]. PLoS One, 2017, 12(3):e0174594.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[6] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[7] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[8] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[9] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[10] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[11] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[12] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[13] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[14] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[15] 谢浩文, 丁建英, 刘小霞, 冯毅, 姚婧. 椎旁神经阻滞对微创胃切除肥胖患者术中血流、术后应激及康复质量的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 569-573.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?